Home Bratislava Medical Journal 2024 Bratislava Medical Journal Vol.125, No.12, p 835–843, 2024

Journal info


 


Published Monthly, in English
Founded: 1919
ISSN 0006-9248
(E)ISSN 1336-0345

Impact factor 1.5

 

Select Journal







Webshop Cart

Your Cart is currently empty.
Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.

Bratislava Medical Journal Vol.125, No.12, p 835–843, 2024

Title: Prostate cancer in Slovakia: last decade overview
Author: Robert BABELA, Vladimir BALAZ, Jan BREZA Jr
Abstract: BACKGROUND: Prostate cancer is a significant health issue worldwide, with varying incidence and mortality rates across different regions. This study focuses on Slovakia, a country with an increasing trend in number of prostate cancer cases. The manuscript aims to provide a comprehensive overview of the burden of prostate cancer in Slovakia, encompassing epidemiological trends, economic impact, diagnostic approaches, and treatment modalities. The study emphasizes the need for effective management strategies and healthcare policies to address the increasing burden of this disease in the Slovak population.
METHODS: This retrospective study utilized data from various Slovak health databases, including the National Cancer Registry, hospital records, and insurance claims from 2009 to 2022. We employed epidemiological measures such as incidence, prevalence, and mortality rates to evaluate the burden of prostate cancer. Economic analysis involved assessing direct costs (hospitalizations, treatments, diagnostics) and indirect costs (lost productivity, disability). Additionally, the study reviewed cost of current diagnostic methods in Slovakia.
RESULTS: The study revealed a steady increase in prostate cancer incidence in Slovakia, with a notable rise in cases among men aged 50 and above. Mortality rates showed a moderate increase, highlighting the disease’s impact on the healthcare system. The economic analysis indicated substantial direct and indirect costs, with a significant portion allocated to advanced treatments and productivity loss. Diagnostic methods showed improvements over time, with increased utilization of advanced imaging techniques.
CONCLUSIONS: The burden of prostate cancer in Slovakia is significant and growing, with rising incidence and economic costs posing challenges to the healthcare system. The study underscores the need for improved and early access to effective diagnostic and treatment options, and robust health policies to manage the rising burden. Additionally, public health initiatives focusing on awareness and early detection could play a crucial role in reducing the impact of prostate cancer in Slovakia. The findings of this study contribute valuable insights for policymakers and healthcare providers in developing targeted strategies to mitigate the burden of prostate cancer in the Slovak population (Tab. 7, Ref. 53).
Keywords: prostate cancer, burden of disease, direct costs, indirect costs, societal impact
Year: 2024, Volume: 125, Issue: 12 Page From: 835, Page To: 843
doi:10.4149/BLL_2024_128


download file


© AEPress s.r.o
Copyright notice: For any permission to reproduce, archive or otherwise use the documents in the ELiS, please contact AEP.